C
ANAB icon

Covestor’s AnaptysBio ANAB Stock Holding History

Covestor’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
9
+7
+350% +$424 ﹤0.01% 2034
2026
Q1 		$0 Sell
2
-3
-60% -$161 ﹤0.01% 2225
2025
Q4 		$0 Sell
5
-6,577
-100% -$256K ﹤0.01% 2232
2025
Q3 		$201K Buy
6,582
+6,577
+131,540% +$151K 0.11% 212
2025
Q2 		$0 Sell
5
-1
-17% -$21 ﹤0.01% 2168
2025
Q1 		$0 Sell
6
-32
-84% -$534 ﹤0.01% 2176
2024
Q4 		$1K Buy
38
+28
+280% +$678 ﹤0.01% 1972
2024
Q3 		$0 Sell
10
-4
-29% -$137 ﹤0.01% 2173
2024
Q2 		$0 Buy
+14
New +$326 ﹤0.01% 2206
2023
Q1 		– Sell
-7
Closed – – 1977
2022
Q4 		$0 Sell
7
-4
-36% -$113 ﹤0.01% 2022
2022
Q3 		$0 Buy
+11
New +$258 ﹤0.01% 1941

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Covestor's ANAB Position: Q2 2026 in Review

Covestor increased its AnaptysBio (ANAB) stake by 350% in Q2 2026, buying an estimated $424 and bringing the position to 9 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

Covestor first reported a position in ANAB in Q3 2022 and has held it in 11 quarters since. The position peaked at $201K in Q3 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Covestor held 9 shares of AnaptysBio worth $1K as of Q2 2026.
  • Covestor bought 7 AnaptysBio shares in Q2 2026, an estimated $424.
  • AnaptysBio made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2034 holding.
  • Covestor first reported a position in AnaptysBio in Q3 2022 and has held it in 11 quarters since.
  • Covestor's AnaptysBio position peaked at $201K in Q3 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.